Pharmaniaga Berhad (KLSE:PHARMA)
Malaysia flag Malaysia · Delayed Price · Currency is MYR
0.2950
+0.0050 (1.72%)
At close: Feb 6, 2026

Pharmaniaga Berhad Cash Flow Statement

Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
43.16131.82-80.16-629.92172.1527.49
Depreciation & Amortization
32.9838.3538.7734.0231.730.76
Other Amortization
7.243.032.932.411.681.58
Other Operating Activities
-92.4-130.5385.41451.15-269.58-85.54
Operating Cash Flow
-9.0242.6746.95-142.34-64.06-25.71
Operating Cash Flow Growth
--9.12%----
Capital Expenditures
-30.28-31.16-50.67-59.26-30.39-9.25
Sale of Property, Plant & Equipment
0.280.081.320.060.210
Sale (Purchase) of Intangibles
-5.71-8.41-10.34-18.38-14.97-23.38
Other Investing Activities
-158.23-6.13-8.245.25-0.41-
Investing Cash Flow
-193.94-45.62-67.93-72.34-45.56-32.64
Short-Term Debt Issued
--50---
Long-Term Debt Issued
-2,1503,2482,2912,3291,541
Total Debt Issued
2,1152,1503,2982,2912,3291,541
Long-Term Debt Repaid
--2,139-3,240-1,988-2,149-1,443
Total Debt Repaid
-2,367-2,139-3,240-1,988-2,149-1,443
Net Debt Issued (Repaid)
-251.7810.6757.48303.42179.7397.72
Issuance of Common Stock
569.57-45.86---
Common Dividends Paid
---7.86-82.53-58.95-26.14
Other Financing Activities
5.3111.43-0.21-0.1-0.04-0.09
Financing Cash Flow
323.122.195.27220.79120.7471.49
Foreign Exchange Rate Adjustments
-0.57-0.520.31-0.390.13-0.23
Net Cash Flow
119.5718.6474.595.7411.2512.91
Free Cash Flow
-39.3111.51-3.72-201.6-94.44-34.96
Free Cash Flow Margin
-1.00%0.31%-0.11%-5.79%-1.96%-1.28%
Free Cash Flow Per Share
-0.020.01-0.00-0.15-0.07-0.03
Cash Interest Paid
63.8668.1160.8141.2932.6338.57
Cash Income Tax Paid
52.1133.8920.5639.5239.72.94
Levered Free Cash Flow
-62-16.5331.75479.12-143.76-75.73
Unlevered Free Cash Flow
-19.9328.4570.4504.15-122.93-54.67
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.